Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 15 of about 15 for valeant
Company Exchange Symbol Last price Quote change Market cap
Valeant Pharmaceuticals Intl Inc TSE VRX 125.94 +1.40 (1.12%) 41.91B
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, ...
Valeant Pharmaceuticals Intl Inc NYSE VRX 115.30 +1.49 (1.31%) 38.38B
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, ...
VALEANT PHARMACEUT. INTL FRA BVF 85.52 +0.13 (0.15%)
Cortex Pharmaceuticals OTCMKTS CORX 0.0490 +0.0080 (19.51%) 7.06M
Cortex Pharmaceuticals, Inc. (Cortex) is engaged in the discovery and development of pharmaceuticals for the treatment of breathing disorders, ...
CORTEX PHARM. DL-,001 FRA PHX 0.009
Actavis PLC Private
Actavis PLC, is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, ...
Dr. Reddy's Laboratories Limited (ADR) NYSE RDY 46.72 -0.04 (-0.09%) 7.96B
Dr. Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, ...
Dr. Reddy's Laboratories Limited NSE DRREDDY 2,822.30 -16.55 (-0.58%) 487.90B
Dr. Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, ...
Dr. Reddy's Laboratories Limited BOM 500124 2,816.90 -21.60 (-0.76%) 486.88B
Dr. Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, ...
ACTAVIS INC. DL-,0033 FRA WAP1 106.36
DR REDDYS LABS ADR/1 IR 5 FRA RDDA 34.38 -0.98 (-2.78%)
Nektar Therapeutics NASDAQ NKTR 13.36 +0.04 (0.30%) 1.70B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
Enzon Pharmaceuticals Inc NASDAQ ENZN 1.28 +0.01 (0.79%) 56.48M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
NEKTAR THERAPEUTICS FRA ITH 9.88 -0.07 (-0.73%)
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.938 +0.012 (1.30%)